Alpha Crest Capital Management LLC Amgen Inc Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $9.58 Million - $10.8 Million	-42,694 Reduced 95.33%	2,092 $472,000
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $8.91 Million - $9.92 Million	38,631 Added 627.64%	44,786 $10.9 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $4.16 Million - $4.6 Million	-18,970 Reduced 75.5%	6,155 $1.49 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $9,148 - $10,469	46 Added 0.18%	25,125 $5.65 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $4.76 Million - $5.57 Million	22,413 Added 840.7%	25,079 $5.33 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $622,724 - $690,867	2,666 New	2,666 $650,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $1.84 Million - $2.15 Million	-8,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.49 Million - $1.77 Million	6,879 Added 484.1%	8,300 $1.91 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $41,063 - $45,666	175 Added 14.04%	1,421 $361,000
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $1.89 Million - $2.32 Million	-9,566 Reduced 88.48%	1,246 $294,000
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $1.01 Million - $1.35 Million	5,565 Added 106.06%	10,812 $2.19 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $2.87 Million - $3.69 Million	-15,182 Reduced 74.32%	5,247 $1.27 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $2.68 Million - $3.21 Million	15,365 Added 303.42%	20,429 $3.95 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $1.8 Million - $2.12 Million	-10,826 Reduced 68.13%	5,064 $933,000
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $2.87 Million - $3.24 Million	15,890 New	15,890 $3.02 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account